HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Linda Wietecha Selected Research

galcanezumab

10/2022A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene-related peptide ligand (galcanezumab) or receptor (erenumab) antagonist.
1/2022Does "wearing off" of efficacy occur in galcanezumab-treated patients at the end of the monthly treatment cycle? Post hoc analyses of four phase III randomized trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Linda Wietecha Research Topics

Disease

7Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2017 - 12/2009
4Dyslexia (Alexia)
01/2017 - 12/2009
3Migraine Disorders (Migraine)
10/2022 - 12/2018
2Sluggish Cognitive Tempo
01/2017 - 11/2013
1Constipation
10/2022
1Pain (Aches)
12/2018
1Headache (Headaches)
12/2018
1Wounds and Injuries (Trauma)
09/2010

Drug/Important Bio-Agent (IBA)

7Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
01/2017 - 12/2009
2galcanezumabIBA
10/2022 - 01/2022
1erenumabIBA
10/2022
1Monoclonal AntibodiesIBA
10/2022
1LigandsIBA
10/2022
1Calcitonin Gene-Related PeptideIBA
10/2022
1Pain-FreeIBA
12/2018
1lasmiditanIBA
12/2018
1TeaIBA
12/2009

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2017